Found 12 matching trials
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC) PHASE1 A Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory,...
Show More Learn More & Join Trial
Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer PHASE1 This phase I trial studies the side effects and best dose of olaparib and o...
Show More Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial
Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status. PHASE2 MAZEPPA is open-label, phase II study to assess the efficacy of a genomic-d...
Show More Status
Active Not Recruiting
Location
Institut Sainte Catherine
Learn More & Join Trial
Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors PHASE1 This is a single center, phase I/Ib clinical trial evaluating the combinati...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents PHASE1 This is a modular, phase I/ phase 1 b, open-label, multicentre study of cer...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Olaparib + Sapacitabine in BRCA Mutant Breast Cancer PHASE1 This research study is studying a combination of drugs as a possible treatm...
Show More Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Learn More & Join Trial
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer PHASE1 Patients whose pancreatic cancers have defects in the BRCA/Fanconi DNA repa...
Show More Location
The Johns Hopkins University School of Medicine
Learn More & Join Trial
Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer PHASE2 Investigational agent, AZD6738 will be given in combination with Olaparib t...
Show More Location
Johns Hopkins University School of Medicine
Learn More & Join Trial
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases PHASE1 This study is a Phase I/II study evaluating the safety and effectiveness of...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma PHASE1 A phase Ib study of Olaparib with concomitant radiotherapy in locally advan...
Show More Location
Institut Bergonié
Learn More & Join Trial